| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) have been net sellers, shedding 112,545 shares worth roughly $1.3M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $29.37M | - | |
| CFO | 248.6K | $2.66M | - | |
| Dir | 124.4K | $1.33M | - | |
| CEO | 70.8K | $758.0K | - | |
| Dir | 63.1K | $674.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $5.25 | $52,500.00 | -14.1% | +67.6% | +22.3% | |
| Mar 5, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $6.79 | $67,900.00 | -12.7% | +16.7% | +17.5% | |
| Feb 14, 2025 | Chris A Rallis60 | Director | Sale+OE10b5-1 | 1,186 | $6.82 | $8,088.52 | -2.2% | -1.9% | +26.0% | |
| Feb 5, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $6.66 | $66,600.00 | -11.6% | -11.5% | +12.8% | |
| Jan 6, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $6.08 | $60,800.00 | -10.7% | -14.3% | +21.4% | |
| Dec 5, 2024 | Rosty Raykov51 | Director | Sell10b5-1 | 796 | $6.04 | $4,807.84 | -1.2% | +18.0% | +32.0% | |
| Dec 3, 2024 | Rosty Raykov51 | Director | Sell10b5-1 | 1,635 | $6.13 | $10,022.55 | -2.4% | +8.7% | +21.5% | |
| Dec 2, 2024 | Chris A Rallis60 | Director | Sale+OE10b5-1 | 6,409 | $6.14 | $39,351.26 | -10.9% | +8.5% | +22.0% | |
| Nov 4, 2024 | Rosty Raykov51 | Director | Sell10b5-1 | 2,431 | $4.31 | $10,477.61 | -3.5% | +39.8% | +72.0% | |
| Oct 8, 2024 | Chris A Rallis60 | Director | Sale+OE10b5-1 | 1,406 | $4.53 | $6,369.18 | -2.8% | +34.8% | +104.4% |